| 1 |
What is the primary goal of the article according to its introduction?
|
3. To explore advancements, applications, and challenges of generative AI in medical imaging |
|
the article title explicitly defines its goal as exploring the opportunities and challenges of generative AI in medical image synthesis,which directly matches option 3
|
exploring the potential of generative artificial intelligence in medical image synthesis:opportunities challenges and future direction
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
How do generative AI models differ from traditional discriminative models in healthcare applications?
|
2. Generative models produce new data rather than only classify or interpret |
|
generative models are defined by their ability to create new data, unlike discriminative models which only classify or interpret existing data
|
generative models learn the joint probability p(x,y) of the data distribution , allowing them to synthesize new samples
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What is meant by the term “model as a dataset”?
|
3. Sharing trained model weights instead of raw data |
|
model as dataset. is a privacy method where the trained model eights are shared as a safe proxy for the original,sensitive raw data
|
based on privacy-preserving AI where model wights statistically summarize the patterns learned from the sensitive dataset
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which statement correctly distinguishes physics-informed and statistical models?
|
3. Physics-informed models incorporate biological or physical principles |
|
physics-informed models incorporate real-world physical or biological laws directly,unlike statistical models that only learn from data correlations.
|
this distinction is based on Hybrid modeling, where physics informed models are mechanistic and use governing equations as constraints
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
According to the article, what does the “image generation trilemma” describe?
|
2. Trade-offs among image diversity, quality, and speed |
|
the trilemma is a standard generative modeling constraint where models must trade off achieving high diversity,high quality,high speed
|
this is the trilemma constraint in generative modeling ,balancing fidelity,diversity,and inference cost
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is the Human Turing Test used for in medical image synthesis?
|
2. To assess realism of synthetic medical images by experts |
|
the human turing test uses experts raters to subjectively determine if synthetic image are realistic and clinically useful.
|
perceptual evaluation method that directly assesses the fidelity of generated images based on human judgment.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which of the following is NOT mentioned as a potential benefit of synthetic data in healthcare?
|
4. Eliminating all medical biases permanently |
|
synthetic data can only mitigate biases by boosting diversity,it cannot permanently eliminate all medical biases,making option 4 realistic
|
the principle is bias mitigation vs elimination.All the other option are realistic benefits but total elimination of bias is an overstatement of the technology capability
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What is one major ethical concern associated with generative AI in medical imaging?
|
2. Data copying and patient reidentification |
|
the ethical risk is that generative models may memorize and reproduce training data, leading to data copying and potential patient reidenrification,violating privacy.
|
this concern is tied to model memorization,where the models training makes it vulnerable to privacy leakage and data extraction attacks.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What regulatory precedent did the article cite for synthetic data technologies?
|
2. FDA clearance of synthetic MRI as image-processing software |
|
the fda clearance of synthetic MRI tool is a key regulatory precedent because it established a pathway for synthetic image generation tools to be classified as image-processing software.
|
a benchmark in regulatory policy, setting a standard for classifying synthetic image tools under existing software frameworks rather than as new medical devices.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What is the main purpose of the article?
|
2. To compare and evaluate ASCVD risk prediction models in East Asia |
|
research aims to validate and improve ASCVD prediction models within a specific region, making the comparison of models in east asia the main purpose.
|
the principle is External validation, which requires checking a model’s performance on a new, distinct population.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
Which of the following models was originally developed for a Western population?
|
1. Framingham Risk Score |
|
the framingham risk score was developed from the framingham heart study,a long term study primarily of a western US population.
|
the core principle is derivation cohort. the models training models foundation is the framingham heart study, making it the only western models listed.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why might Western-based risk prediction models overestimate ASCVD risk in East Asian populations?
|
2. East Asians have lower baseline incidence of ASCVD |
|
western models use a higher baseline risk in their original population. when applied to east asians with a naturally lower incidence of ASCVD, the models training makes incorrectly overestimates the risk.
|
the issue is model calibration. overestimation occurs because the baseline risk of the western derivation cohort is significantly higher than that of the east asian population.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What is the key advantage of the China-PAR model compared to Western-based models?
|
4. It was calibrated using national data representing diverse regions in China |
|
the china-PAR model’s advantage is it’s superior calibration because it was developed using diverse national data from the population it is meant to serve.
|
Model calibration, ensuring the models baseline risk and factors are accurate for the specific derivation cohort.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which of the following variables is not typically included in ASCVD risk prediction models discussed in the article?
|
4. Genetic ancestry markers |
|
traditional ASCVD models use standard clinical inputs, because they’re easy to get,they do not typically include complex genetic ancestry markers.
|
Clinical feasibility. standard models use only readily available biometric variables, leaving complex genetic ancestry markers for specialized research.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
What is a major difference between the Suita Score and the Framingham Risk Score?
|
2. Suita Score was designed for a Japanese population using local epidemiological data |
|
derivation population. the suita score was created using local japanese’s epidemiological data, giving it better accuracy for east asians,while framingham uses data from a western population
|
regional specificity. the suita score is an ethnicity-specific model, contrasting with the western-derived framingham model.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what is a potential benefit of developing East Asia–specific risk models?
|
3. They improve accuracy and reduce overestimation of risk |
|
developing east asia-specific models is a benefit because they use correct local data for calibration,which directly improves prediction accuracy and fixes the overestimation error of western models.
|
Model calibration.A regional model ensures superior accuracy because it accounts for the true baseline incidence of ASVD in that specific population.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
Which factor was highlighted as influencing ASCVD risk differences among East Asian countries?
|
2. Cultural and dietary variations, such as salt intake and lifestyle |
|
difference in diet and lifestyle across east asia creat risk heterogeneity.this difference is a major non- genetic factor influencing ASCVD risk variation.
|
Environmental risk heterogeneity.local variations in diets and culture are key non-genetic risk factors that necessitate the development of country-specific ASCVD.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What future direction does the article suggest for improving ASCVD risk prediction?
|
2. Using multimodal AI-based prediction integrated with regional data |
|
the future requires using AI with multimodal data and integrating regional data to ensure high accuracy and correct calibration.
|
Holistic and calibrated prediction is holistic and calibrated prediction, moving toward multimodal and away from older,single-factor, uncalibrated risk scores
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
Which statement best explains the key difference in how VAEs, GANs, and DDPMs generate medical images according to the figure?
|
3. DDPMs iteratively remove noise through reverse diffusion rather than using encoder–decoder or discriminator structures. |
|
DDPMs are unique as they generate images by iteratively removing noise , a fundamentallly different process from the encoder-decoder or generator discriminator structures.
|
generative model architecture. DDPMs use a markov chain denoising process, VAEs use variations inference and GANs use adversarial learning.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Which of the following best explains the trend shown in Figure comparing age-standardized and crude CVD mortality rates among East Asian countries?
|
3. Despite differences in age structures, Japan maintains low mortality rates in both measures, suggesting effective prevention and healthcare systems. |
|
japan’s consistently low mortality rate in both age-standardized and crude measures confirm the effectiveness of its prevention and healthcare system, as the low rate isn’t just due to a young population.
|
interpretation of age-standardized rates. A low rate that persist after age-standardization indicates the effectiveness of public health measures.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|